Australia markets close in 4 hours 48 minutes

StageZero Life Sciences Ltd. (61N1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.01750.0000 (0.00%)
At close: 08:12AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 3.34M
Enterprise value 4.57M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.73
Price/book (mrq)4.78
Enterprise value/revenue 1.72
Enterprise value/EBITDA -2.39

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3-37.50%
S&P500 52-week change 328.04%
52-week high 30.0415
52-week low 30.0145
50-day moving average 30.0188
200-day moving average 30.0244

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5123.55M
Implied shares outstanding 6190.85M
Float 881.54M
% held by insiders 119.99%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:8
Last split date 318 Sept 2020

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-56.64%

Management effectiveness

Return on assets (ttm)-63.80%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.88M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-33.00%
Gross profit (ttm)N/A
EBITDA -4.46M
Net income avi to common (ttm)-12.53M
Diluted EPS (ttm)-0.1100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.54k
Total cash per share (mrq)0
Total debt (mrq)1.77M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.04
Book value per share (mrq)-0.07

Cash flow statement

Operating cash flow (ttm)-809.15k
Levered free cash flow (ttm)1.18M